Your browser doesn't support javascript.
loading
Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?
Morote, Juan; Campistol, Miriam; Regis, Lucas; Celma, Anna; de Torres, Inés; Semidey, Maria E; Roche, Sarai; Mast, Richard; Santamaria, Anna; Planas, Jacques; Trilla, Enrique.
Affiliation
  • Morote J; Department of Urology, 16810Vall d´Hebron Hospital, Barcelona, Spain.
  • Campistol M; Prostate Cancer Research Group, Vall d´Hebron Research Institute, Barcelona, Spain.
  • Regis L; Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Celma A; Department of Urology, 16810Vall d´Hebron Hospital, Barcelona, Spain.
  • de Torres I; Department of Urology, 16810Vall d´Hebron Hospital, Barcelona, Spain.
  • Semidey ME; Prostate Cancer Research Group, Vall d´Hebron Research Institute, Barcelona, Spain.
  • Roche S; Department of Urology, 16810Vall d´Hebron Hospital, Barcelona, Spain.
  • Mast R; Prostate Cancer Research Group, Vall d´Hebron Research Institute, Barcelona, Spain.
  • Santamaria A; Prostate Cancer Research Group, Vall d´Hebron Research Institute, Barcelona, Spain.
  • Planas J; Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Trilla E; Department of Pathology, 16810Vall d´Hebron Hospital, Barcelona, Spain.
Int J Biol Markers ; 37(2): 218-223, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35200058

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Multiparametric Magnetic Resonance Imaging Type of study: Observational_studies Limits: Humans / Male Language: En Journal: Int J Biol Markers Journal subject: BIOQUIMICA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Spain Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Multiparametric Magnetic Resonance Imaging Type of study: Observational_studies Limits: Humans / Male Language: En Journal: Int J Biol Markers Journal subject: BIOQUIMICA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Spain Country of publication: United States